ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2022

Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling.

Yosef Tsegaye Dabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.